Similar Papers

Paper Title
Journal
Date
Author
Outcomes for metastatic triple-negative (TN) breast cancer: Impact for clinical practice and trial design
...
Journal of Clinical Oncology | VOL. 26
, et. al. ...
20 May 2008
Abstract P1-05-26: Genomic analysis of molecular discordance of paired primary and recurrent triple negative breast cancer
Y Yuan ... A Li
Cancer Research | VOL. 77
Y Yuan, et. al.Y Yuan ... A Li
15 Feb 2017
Cisplatin with veliparib or placebo in metastatic triple-negative breast cancer and BRCA mutation-associated breast cancer (S1416): a randomised, double-blind, placebo-controlled, phase 2 trial.
...
The Lancet Oncology | VOL. 24
, et. al. ...
01 Feb 2023
Abstract PO1-06-12: Phase II study of sitravatinib plus tislelizumab with or without nab-paclitaxel in patients with locally recurrent or metastatic triple negative breast cancer
Lei Fan ... Zhi-Ming Shao
Cancer Research | VOL. 84
Lei Fan, et. al.Lei Fan ... Zhi-Ming Shao
02 May 2024
View more papers

More From: Future oncology (London, England)

Paper Title
Journal
Date
Author
Real-world treatment patterns and health outcomes for patients with myelofibrosis treated with fedratinib.
Francesco Passamonti ... Samantha Slaff
Future oncology (London, England) | VOL. -
Francesco Passamonti, et. al.Francesco Passamonti ... Samantha Slaff
26 Jan 2025
Evaluating patients on CDK-4/6 inhibitor treatment for differences in treatment according to demographic variables.
Sneha Rajendran ... Margaret Q Rosenzweig
Future oncology (London, England) | VOL. -
Sneha Rajendran, et. al.Sneha Rajendran ... Margaret Q Rosenzweig
26 Jan 2025
A plain language summary of the ICARIA study, comparing isatuximab-pomalidomide- dexamethasone with pomalidomide- dexamethasone in people with multiple myeloma.
Paul G Richardson ... Kenneth C Anderson
Future oncology (London, England) | VOL. -
Paul G Richardson, et. al.Paul G Richardson ... Kenneth C Anderson
24 Jan 2025
Enzalutamide with standard first-line therapy for metastatic hormone-sensitive prostate cancer: a plain language summary of the ENZAMET trial (ANZUP 1304).
Ciara Conduit ...
Future oncology (London, England) | VOL. -
Ciara Conduit, et. al.Ciara Conduit ...
17 Jan 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.